Concepedia

G Lübben

GL

Statistics

Publications

30

Citations

1.9K

H-Index

22

Active since

1999

Affiliations

Takeda (Germany)(Current)

Institut für Klinische Forschung und Entwicklung

Profil Institute for Metabolic Research

University of Cologne

Hochschule Bonn-Rhein-Sieg

G Lübben is an author at Takeda (Germany) specializing in medicine, diabetes mellitus, and insulin resistance.

Publications per year

1999–2010

30

Publications

30

Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control

Andreas Pfützner, Nikolaus Marx, G Lübben et al. · Journal of the American College of Cardiology · 2005 · 270 citations

, , +15

Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus

Matthias Langenfeld, Thomas Först, C Hohberg et al. · Circulation · 2005 · 265 citations · Full text

, , +15

Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein

M Hanefeld, Nikolaus Marx, Andreas Pfützner et al. · Journal of the American College of Cardiology · 2007 · 161 citations

, , +13

Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes

Andreas Pfützner, T. Kunt, C Hohberg et al. · Diabetes Care · 2004 · 149 citations · Full text

, , +13

Effects of Pioglitazone in Nondiabetic Patients with Arterial Hypertension: A Double-Blind, Placebo-Controlled Study

S. Füllert, Frank Schneider, Eva Haak et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 122 citations · Full text

, , +15

1–5 of 30